Clinical features and prognosis of drug-induced liver injury in patients with non-alcoholic fatty liver

Table 10 Analysis of immunological function results in the two groups

	DILI (n = 76)	DILI + NAFL (n = 98)	P value
C3 (g/L)	1.165 (0.99, 1.38)	1.27 (1.15, 1.4)	0.02
IgG (g/L)	13.3 (11.21, 16.09)	13.44 (10.84, 15.53)	0.714
C4 (g/L)	0.25 (0.19, 0.31)	0.26 (0.22, 0.31)	0.244
IgM (g/L)	1.01 (0.83, 1.48)	0.94 (0.72, 1.30)	0.047
IgA (g/L)	2.22 (1.89, 2.79)	2.43 (2.01, 3.35)	0.369

C3: Complement c3; IgG: Immunoglobulin G; C4: Complement c4; IgM: Immunoglobulin M; IgA: Immunoglobulin G; DILI: Drug-induced liver injury; NAFL: Nonalcoholic fatty liver.